TipRanks
Go Ultimate55% OFF

60 Degrees Pharmaceuticals, Inc. (SXTP) Stock Forecast & Price Target

244 Followers
See the Price Targets and Ratings of:

SXTP Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to 60 Degrees Pharmaceuticals, Inc. in the past 3 months

SXTP Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for SXTP
Price TargetFollowArticle
H.C. Wainwright―hold―Reiterated08/18/26
Ascendiant$4.20→$3.70buy287.03%UpsideReiterated05/22/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering 60 Degrees Pharmaceuticals, Inc.

3 Months
Lucas Ward
Lucas WardAscendiant
Success Rate1/9 ratings generated profit
11%
Average Return
-23.37%

Copying Lucas Ward's trades and holding each position for 3 Months would result in 11.11% of your transactions generating a profit, with an average return of -23.37% per trade.

1 Year
Lucas Ward
Lucas WardAscendiant
Success Rate0/9 ratings generated profit
0%
Average Return
-75.41%

Copying Lucas Ward's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -75.41% per trade.

2 Years
Lucas Ward
Lucas WardAscendiant
Success Rate0/9 ratings generated profit
0%
Average Return
-83.27%

Copying Lucas Ward's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -83.27% per trade.

SXTP Analyst Recommendation Trends

01234Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for SXTP
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy21000
Buy00000
Hold11111
Sell00000
Strong Sell00000
total32111

In the current month, SXTP has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. SXTP average Analyst price target in the past 3 months is ―.

SXTP Financial Forecast

$-6$-4.5$-3$-1.5$0Q3 2025Q2 2026Q3 2026
High$-0.61
Consensus$-0.61
Low$-0.61

SXTP Earnings Forecast

Next quarter’s earnings estimate for SXTP is -$0.61 with a range of -$0.61 to -$0.61. The previous quarter’s EPS was -$0.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$162,091$253,709$345,327$436,945$528,563Q3 2025Q2 2026Q3 2026
High$270K
Consensus$270K
Low$270K

SXTP Sales Forecast

Next quarter’s sales forecast for SXTP is $270.00K with a range of $270.00K to $270.00K. The previous quarter’s sales results were $207.90K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

SXTP Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SXTP a Buy, Sell or Hold?
60 Degrees Pharmaceuticals, Inc. has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What do analysts say about 60 Degrees Pharmaceuticals, Inc.?
60 Degrees Pharmaceuticals, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of SXTP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.